mt-0169
·Code: MT-0169
mt-0169: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Molecular Templates, Inc. (MTEM) | Preclinical |
FDA Decisions
FDA_MeetingThe Company plans to continue discussions with the FDA with respect to MT-0169 for autoimmune indications.(MTEM)
Frequently asked questions
Who is developing mt-0169?
mt-0169 is being developed by Molecular Templates, Inc..
What is mt-0169's latest FDA decision?
The most recent tracked FDA decision for mt-0169 is FDA_Meeting for The Company plans to continue discussions with the FDA with respect to MT-0169 for autoimmune indications..
Get deeper analysis on mt-0169
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis